Charlotte Hannigan is a Director of Business Development at Quotient Sciences. She plays a key role in supporting the company’s mission to accelerate drug development for pharmaceutical and biotech partners. With a deep understanding of the drug development life cycle, she is responsible for driving strategic client engagement, identifying new business opportunities and fostering long term partnerships that align with Quotient’s services.

Charlotte brings extensive industry experience having worked across various areas of the pharmaceutical sector with a focus on early phase development. She is passionate about helping clients streamline their development timelines by leveraging Quotients unique Translational Pharmaceutics platform.

Charlotte holds a Bachelor’s degree in Forensic Biology with Criminology from the University of Chester and Master’s degree in Pharmaceutical Industrial Advanced Training from the University of Manchester. This academic foundation, combined with hands on industry knowledge, enables her to provide insightful guidance to clients navigating complex development pathways.